A notable Ethereum reserve company in the US stock market, ETHZilla (formerly known as 180 Life Sciences), recently announced a significant decision. The company has reached a revised sales agreement with Clear Street LLC, aiming to raise funds through the issuance of common stock on an irregular basis, with a maximum target set at an astonishing $10 billion.

This initiative has sparked widespread attention in the market. As of the announcement, ETHZilla has issued 5,001,310 shares of common stock according to the original sales agreement, raising approximately $34.4 million in total. It is worth noting that, effective from the date this supplemental prospectus becomes effective, the company will no longer issue common stock based on the 'market issuance prospectus' submitted on August 13, 2025.

The large-scale fundraising plan and protocol adjustment by ETHZilla may indicate the company's intention to further strengthen its position in the Ethereum reserve sector. As a company focused on ETH reserves in the US stock market, this move by ETHZilla will undoubtedly attract close attention from cryptocurrency investors and market analysts.

This development also reflects the growing influence of cryptocurrencies, particularly Ethereum, in traditional financial markets. The strategic adjustment of ETHZilla may indicate a trend of further integration between crypto assets and traditional finance, while also providing investors with a new way to indirectly participate in the cryptocurrency market through the stock market.

With the advancement of this new initiative, the market will closely watch the subsequent actions of ETHZilla and the potential impact of this large-scale financing plan on the Ethereum ecosystem. In any case, this event highlights the increasing importance of cryptocurrency in the global financial landscape.